ursolic acid has been researched along with Diabetic Angiopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asmis, R; Ullevig, SL; Zamora, D; Zhao, Q | 1 |
| Tannock, LR | 1 |
2 other study(ies) available for ursolic acid and Diabetic Angiopathies
| Article | Year |
|---|---|
Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.
Topics: Animals; Aortic Diseases; Atherosclerosis; Cardiovascular Agents; Cell Line; Chemokine CCL2; Chemotaxis, Leukocyte; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Humans; Hyperlipidemias; Kidney; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Oxidative Stress; Receptors, CCR2; Receptors, LDL; Resveratrol; Stilbenes; Time Factors; Triterpenes; Ursolic Acid | 2011 |
Ursolic acid effect on atherosclerosis: apples and apples, or apples and oranges?
Topics: Animals; Aortic Diseases; Apoptosis; Atherosclerosis; Cardiovascular Agents; Caspases; Diabetes Mellitus, Experimental; Diabetic Angiopathies; DNA Damage; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mitochondria; Monocytes; Plaque, Atherosclerotic; Triterpenes; Tumor Suppressor Protein p53; Ursolic Acid | 2011 |